Neurocrine Biosciences Inc (NBIX)
Who owns Neurocrine Biosciences Inc (NBIX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.2% of the shares are freely tradable; institutional investors hold 103.9%.
Ownership Structure
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 13.31 | 13,385,607 | +4.3 | 03/31/2026 |
| Dodge & Cox | 5.43 | 5,461,037 | -0.9 | 03/31/2026 |
| JPMorgan Chase & Co | 5.41 | 5,442,067 | +4.6 | 03/31/2026 |
| AQR Capital Management LLC | 4.91 | 4,938,967 | +51.0 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 4.70 | 4,726,344 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.49 | 4,511,904 | +0.0 | 03/31/2026 |
| State Street Corp | 4.33 | 4,354,526 | +2.6 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Dodge & Cox Stock I | 3.94 | 3,964,000 | +0.0 | 06/30/2026 |
| iShares Core S&P Mid-Cap ETF | 3.43 | 3,453,501 | +0.0 | 07/30/2026 |
| Vanguard Morn Total Stk Mkt Idx Investor | 3.18 | 3,193,839 | +0.0 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 29. Jul 2026 | Norwalk Leslie V | Director | Other | 842 | 139.43 | 117,400 |
| 28. Jul 2026 | Norwalk Leslie V | Director | Sell | 1,250 | 182.01 | 227,508 |
| 10. Jul 2026 | Delaet Ingrid | Chief Regulatory Officer | Sell | 4,367 | 181.02 | 790,514 |
| 10. Jul 2026 | Delaet Ingrid | Chief Regulatory Officer | Other | 4,367 | 106.02 | 462,989 |
| 9. Jul 2026 | Lippoldt Darin | Chief Legal Officer | Sell | 10,000 | 179.60 | 1,796,014 |
| 9. Jul 2026 | Lippoldt Darin | Chief Legal Officer | Other | 10,000 | 81.49 | 814,900 |
| 9. Jul 2026 | Delaet Ingrid | Chief Regulatory Officer | Sell | 8,433 | 178.72 | 1,507,135 |
| 9. Jul 2026 | Delaet Ingrid | Chief Regulatory Officer | Other | 8,433 | 103.52 | 872,984 |
| 8. Jul 2026 | Delaet Ingrid | Chief Regulatory Officer | Sell | 2,737 | 178.54 | 488,672 |
| 8. Jul 2026 | Delaet Ingrid | Chief Regulatory Officer | Other | 2,737 | 103.52 | 283,334 |
| 7. Jul 2026 | Delaet Ingrid | Chief Regulatory Officer | Sell | 3,401 | 178.57 | 607,305 |
| 7. Jul 2026 | Delaet Ingrid | Chief Regulatory Officer | Other | 3,401 | 103.52 | 352,072 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.